- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04265729
Neocate In Infants and Children With Complex Conditions (NICC)
An Open-label, Explorative, Post Launch Study of Neocate Amino Acid-based Feeds to Evaluate Nutritional Status and Gastrointestinal Tolerance in Infants and Children With Complex Conditions
Infants and young children up to 10 years of age with a complex condition involving the gastrointestinal tract are at risk of poor nutritional status, including faltering growth. Due to the complex condition, standard nutrition is often not tolerated and causes gastrointestinal symptoms.
Formulas in which protein is replaced by its smallest elements, amino acids are easier for the body to digest and absorb. These formulas might be tolerated better and reduce gastrointestinal symptoms in infants and young children with complex conditions.
The objectives of the present, exploratory study are to gain clinical evidence related to the nutritional status and gastrointestinal tolerance in infants and young children with complex conditions receiving Neocate as their primary source of nutrition. Additional objectives are to describe the nutritional and pharmacological management of these infants and young children. Study duration for each participant will be 52 weeks at maximum.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Danone Nutricia Research
- Numero di telefono: +31 30 295000
- Email: register.clinicalresearchnutricia@danone.com
Luoghi di studio
-
-
-
Munich, Germania
- Dr. von Haunersches LKinderspital
-
Contatto:
- Prof. Dr. S. Koletzko
-
-
-
-
-
London, Regno Unito
- Great Ormond Street Hospital
-
Contatto:
- Dr. O. Borrelli
-
-
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30342
- GI Care for Kids
-
Contatto:
- Dr. B. Gold
-
-
South Carolina
-
Greenville, South Carolina, Stati Uniti, 29615
- Prisma Health - Upstate
-
Contatto:
- Dr. M. Dougherty
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Infants and young children aged from 0 up to and including 10 years of age.
- Severe impairment of at least 1 organ system
- Impairment of the gastrointestinal tract, i.e. gastrointestinal disease, congenital abnormality, surgical resection, or gastrointestinal dysfunction (including symptoms of gastrointestinal dysmotility or malabsorption).
- Receiving at least 75% of their energy intake from Neocate (Neocate Infant or Junior powdered (marketed) product) at the time of study entry (V1).
- Expected to receive at least 75% of their energy intake from the study product for at least 4 weeks from study entry (V1).
- Written informed consent provided by parents/guardians and assent by the child, if applicable, according to local law.
Exclusion Criteria:
- Infants born with a gestational age <37 weeks that are <40 weeks corrected age at the time of study entry (V1).
- Infants or children with endoscopically confirmed eosinophilic oesophagitis and prescribed an amino acid-based formula only for the management of the eosinophilic oesophagitis.
- Infants or children with a medical diagnosis that includes only (suspected) cow's milk allergy and/or multiple food allergy.
- Infants or children with renal dysfunction, e.g. acute or chronic kidney failure or kidney cancer.
- Infants or children with thyroid disorder or parathyroid disorder.
- Expected to receive parenteral nutrition during intervention from study entry (V1).
- Participation in any other studies involving investigational or marketed products concomitantly or within 1 month prior to study entry (V1).
- Investigator's uncertainty about the willingness or ability of the parents/guardians to comply with the protocol requirements.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Altro: single test product arm
use of Neocate Infant and Junior marketed products (product type depending on subject's age and condition)
|
use of Neocate Infant and Junior marketed products
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Exploratory: Weight
Lasso di tempo: 0 weeks
|
Weight [in g/kg]
|
0 weeks
|
Exploratory: Weight
Lasso di tempo: 4 weeks
|
Weight [in g/kg]
|
4 weeks
|
Exploratory: Weight
Lasso di tempo: 16 weeks
|
Weight [in g/kg]
|
16 weeks
|
Exploratory: Weight
Lasso di tempo: 52 weeks
|
Weight [in g/kg]
|
52 weeks
|
Exploratory: Length
Lasso di tempo: 0 weeks
|
Length/height [in cm]
|
0 weeks
|
Exploratory: Length
Lasso di tempo: 4 weeks
|
Length/height [in cm]
|
4 weeks
|
Exploratory: Length
Lasso di tempo: 16 weeks
|
Length/height [in cm]
|
16 weeks
|
Exploratory: Length
Lasso di tempo: 52 weeks
|
Length/height [in cm]
|
52 weeks
|
Exploratory: head circumference
Lasso di tempo: 0 weeks
|
head circumference (for children <2 years of age) [in cm]
|
0 weeks
|
Exploratory: head circumference
Lasso di tempo: 4 weeks
|
head circumference (for children <2 years of age) [in cm]
|
4 weeks
|
Exploratory: head circumference
Lasso di tempo: 16 weeks
|
head circumference (for children <2 years of age) [in cm]
|
16 weeks
|
Exploratory: head circumference
Lasso di tempo: 52 weeks
|
head circumference (for children <2 years of age) [in cm]
|
52 weeks
|
Exploratory: Biochemical markers of nutritional status
Lasso di tempo: 0 weeks
|
Macronutrient, micronutrient and mineral levels in blood [in a.o.
mmol/L]
|
0 weeks
|
Exploratory: Biochemical markers of nutritional status
Lasso di tempo: 4 weeks
|
Macronutrient, micronutrient and mineral levels in blood [in a.o.
mmol/L]
|
4 weeks
|
Exploratory: Biochemical markers of nutritional status
Lasso di tempo: 16 weeks
|
Macronutrient, micronutrient and mineral levels in blood [in a.o.
mmol/L]
|
16 weeks
|
Exploratory: Biochemical markers of nutritional status
Lasso di tempo: 52 weeks
|
Macronutrient, micronutrient and mineral levels in blood [in a.o.
mmol/L]
|
52 weeks
|
Exploratory: Gastrointestinal tolerance
Lasso di tempo: 0 weeks
|
GastrointestinaI symptoms [none/mild/moderate/severe]
|
0 weeks
|
Exploratory: Gastrointestinal tolerance
Lasso di tempo: 4 weeks
|
GastrointestinaI symptoms [none/mild/moderate/severe]
|
4 weeks
|
Exploratory: Gastrointestinal tolerance
Lasso di tempo: 16 weeks
|
GastrointestinaI symptoms [none/mild/moderate/severe]
|
16 weeks
|
Exploratory: Gastrointestinal tolerance
Lasso di tempo: 52 weeks
|
GastrointestinaI symptoms [none/mild/moderate/severe]
|
52 weeks
|
Exploratory: Stool frequency
Lasso di tempo: 0 weeks
|
number of stools per day
|
0 weeks
|
Exploratory: Stool frequency
Lasso di tempo: 4 weeks
|
number of stools per day
|
4 weeks
|
Exploratory: Stool frequency
Lasso di tempo: 16 weeks
|
number of stools per day
|
16 weeks
|
Exploratory: Stool frequency
Lasso di tempo: 52 weeks
|
number of stools per day
|
52 weeks
|
Exploratory: Stool consistency
Lasso di tempo: 0 weeks
|
parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery
|
0 weeks
|
Exploratory: Stool consistency
Lasso di tempo: 4 weeks
|
parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery
|
4 weeks
|
Exploratory: Stool consistency
Lasso di tempo: 16 weeks
|
parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery
|
16 weeks
|
Exploratory: Stool consistency
Lasso di tempo: 52 weeks
|
parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery
|
52 weeks
|
Exploratory: Nutrient intake
Lasso di tempo: 0 weeks
|
calculated energy, protein and micronutrient levels from parent diary [in a.o.
mg/d]
|
0 weeks
|
Exploratory: Nutrient intake
Lasso di tempo: 4 weeks
|
calculated energy, protein and micronutrient levels from parent diary [in a.o.
mg/d]
|
4 weeks
|
Exploratory: Nutrient intake
Lasso di tempo: 16 weeks
|
calculated energy, protein and micronutrient levels from parent diary [in a.o.
mg/d]
|
16 weeks
|
Exploratory: Nutrient intake
Lasso di tempo: 52 weeks
|
calculated energy, protein and micronutrient levels from parent diary [in a.o.
mg/d]
|
52 weeks
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Anticipato)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MPR18TA23134
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .